Industry News

FDA Advisory Committee Recommends Approval of Natpara� for Long-Term Treatment of Hypoparathyroidism
Acadia Pharmaceuticals: FDA Grants Trade Name Nuplazid for Pimavanserin
Hospira Issues a Voluntary Nationwide Recall of One Lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9% Sodium...
Rutgers Receives $10 Million Pledge to Advance Treatment of Cancer Patients
United States : Baxter Announces Baxalta as the Name of the New Global Biopharmaceutical Company
California biotech firm to hire 100-plus to make cancer drugs in University Research Park
Covidien Acquires Sapheon
WholeHealth Products announces the release of the FDA Cleared "Troponin I" rapid test
Teva Launches SYNCare Home Administration Support Program for Patients on SYNRIBO Omacetaxine Mepesuccinate for Injection Teva
ConvaTec Introduces New Urostomy Pouch Designed for Unmatched Comfort, Discretion and Security Pouch System with Moldable Technology for Clinically Proven Leak and Skin Protection
Cantrell Drug Company Enhances Compounding Safety with Closed Vial Filling System from Aseptic Technologies
Lilly receives European marketing OK for insulin
ConvaTec Introduces New Urostomy Pouch Designed for Unmatched Comfort, Discretion and Security Pouch System with Moldable Technology� for Clinically Proven Leak and Skin Protection
FDA allows marketing of the first test to assess risk of developing acute kidney injury
Marathon Pharmaceuticals Launches ZiNGO (lidocaine hydrochloride monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic to Manage Venous Access Pain
New drug-free device meets unmet need
Merck Secures FDA Approval of Keytruda
AbbVie sued by FTC for paying to delay generic drug
U.S. Expediting Zmapp Production, Contracts Services Drug Producer
Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex
Neos Therapeutics Acquires all Commercialization and Profit Rights to Generic Tussionex (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) from Chiesi USA and Coating Place, Inc.
BYDUREON Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies
Sosei Group Announces Positive Results for Ultibro and Seebri Presented at ERS 2014, and Promotion Agreement with Pfizer in the UK
FDA allows marketing of the first test to assess risk of developing acute kidney injury
Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis --Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection----AMC Healt